Elevated Regulatory T Cell Levels in Glaucoma Patients in Comparison to Healthy Controls

References

• Gutteridge IF. Normal tension glaucoma: diagnostic features and comparisons with primary open angle glaucoma. Clin Exp Optom 2000;83(3):161–172.
   PubMedGoogle Scholar
• Okisaka S, Murakami A, Mizukawa A, Ito J. Apoptosis in retinal ganglion cell decrease in human glaucomatous eyes. Jpn J Ophthalmol 1997;41(2):84–88.
   PubMed Web of Science ®Google Scholar
• Agar A, Li S, Agarwal N, Coroneo MT, Hill MA. Retinal ganglion cell line apoptosis induced by hydrostatic pressure. Brain Res 2006;1086(1):191–200.
   PubMed Web of Science ®Google Scholar
• Wax MB, Barrett DA, Pestronk A. Increased incidence of paraproteinemia and autoantibodies in patients with normal-pressure glaucoma. Am J Ophthalmol. 1994;117(5):561–568.
   PubMed Web of Science ®Google Scholar
• Wax MB, Tezel G, Saito I, Gupta RS, Harley JB, Li Z, et al. Anti-Ro/SS-A positivity and heat shock protein antibodies in patients with normal-pressure glaucoma. Am J Ophthalmol 1998;125(2):145–157.
   PubMed Web of Science ®Google Scholar
• Ikeda Y, Maruyama I, Nakazawa M, Ohguro H. Clinical significance of serum antibody against neuron-specific enolase in glaucoma patients. Jpn J Ophthalmol 2002;46(1):13–17.
   PubMed Web of Science ®Google Scholar
• Joachim SC, Reichelt J, Berneiser S, Pfeiffer N, Grus FH. Sera of glaucoma patients show autoantibodies against myelin basic protein and complex autoantibody profiles against human optic nerve antigens. Graefes Arch Clin Exp Ophthalmol 2008;246(4):573–580.
   PubMed Web of Science ®Google Scholar
• Tezel G, Edward DP, Wax MB. Serum autoantibodies to optic nerve head glycosaminoglycans in patients with glaucoma. Arch Ophthalmol 1999;117(7):917–924.
   PubMed Web of Science ®Google Scholar
• Fremd C, Schuetz F, Sohn C, Beckhove P, Domschke C. B cell-regulated immune responses in tumor models and cancer patients. Oncoimmunology 2013;2(7):e25443.
   PubMed Web of Science ®Google Scholar
• Ohl K, Tenbrock K. Regulatory T cells in systemic lupus erythematosus. Eur J Immunol 2015;45(2):344–355.
   PubMed Web of Science ®Google Scholar
• Grant CR, Liberal R, Mieli-Vergani G, Vergani D, Longhi MS. Regulatory T-cells in autoimmune diseases: challenges, controversies and–yet–unanswered questions. Autoimmun Rev 2015;14(2):105–116.
   PubMed Web of Science ®Google Scholar
• He F, Balling R. The role of regulatory T cells in neurodegenerative diseases. Wiley Interdiscip Rev Syst Biol Med 2013;5(2):153–180.
   PubMed Web of Science ®Google Scholar
• Tham YC, Li X, Wong TY, Quigley HA, Aung T, Cheng CY. Global prevalence of glaucoma and projections of glaucoma burden through 2040: A systematic review and meta-analysis. Ophthalmology. 2014 ;121(11):2081–2090.
   Web of Science ®Google Scholar
• Przedborski S, Vila M, Jackson-Lewis V. Neurodegeneration: what is it and where are we? J Clin Invest 2003;111(1):3–10.
   PubMed Web of Science ®Google Scholar
• Wax MB, Tezel G. Immunoregulation of retinal ganglion cell fate in glaucoma. Exp Eye Res 2009;88(4):825–830.
   PubMed Web of Science ®Google Scholar
• Bell K, Gramlich OW, Von Thun Und Hohenstein-Blaul N, Beck S, Funke S, Wilding C, et al. Does autoimmunity play a part in the pathogenesis of glaucoma? Prog Retin Eye Res 2013;36:199–216.
   PubMed Web of Science ®Google Scholar
• Tezel G, Thornton IL, Tong MG, Luo C, Yang X, Cai J, et al. Immunoproteomic analysis of potential serum biomarker candidates in human glaucoma. Invest Ophthalmol Vis Sci 2012;53(13):8222–8231.
   PubMed Web of Science ®Google Scholar
• Yang J, Patil RV, Yu H, Gordon M, Wax MB. T cell subsets and sIL-2R/IL-2 levels in patients with glaucoma. Am J Ophthalmol 2001;131(4):421–426.
   PubMed Web of Science ®Google Scholar
• Gandolfi S, Aldigieri R, Ungaro N, Tardini MG, Paoli D, Giacosa F. The increased level of circulating and functioning Treg Lymphocytes correlates with visual field rate of progression in Primary Open Angle Glaucoma. World Glaucoma Congress. 2011;Clinical Glaucoma:348.
   Google Scholar
• Bonelli M, Goschl L, Bluml S, Karonitsch T, Steiner CW, Steiner G, et al. CD4(+)CD25(-)Foxp3(+) T cells: a marker for lupus nephritis? Arthritis Res Ther 2014;16(2):R104.
   PubMed Web of Science ®Google Scholar
• Wada J, Yamasaki A, Nagai S, Yanai K, Fuchino K, Kameda C, et al. Regulatory T-cells are possible effect prediction markers of immunotherapy for cancer patients. Anticancer Res 2008;28(4C):2401–2408.
   Web of Science ®Google Scholar
• Lourenco EV, La Cava A. Natural regulatory T cells in autoimmunity. Autoimmunity 2011;44(1):33–42.
   PubMed Web of Science ®Google Scholar
• Crispin JC, Martinez A, Alcocer-Varela J. Quantification of regulatory T cells in patients with systemic lupus erythematosus. J Autoimmun 2003;21(3):273–276.
   PubMed Web of Science ®Google Scholar
• Erfani N, Mehrabadi SM, Ghayumi MA, Haghshenas MR, Mojtahedi Z, Ghaderi A, et al. Increase of regulatory T cells in metastatic stage and CTLA-4 over expression in lymphocytes of patients with non-small cell lung cancer (NSCLC). Lung Cancer 2012;77(2):306–311.
   PubMed Web of Science ®Google Scholar
• Choi HY, Lee JE, Lee JW, Park HJ, Lee JE, Jung JH. In vitro study of antiadipogenic profile of latanoprost, travoprost, bimatoprost, and tafluprost in human orbital preadiopocytes. J Ocul Pharmacol Ther 2012;28(2):146–152.
   PubMed Web of Science ®Google Scholar
• Cannon MJ, Petroff MG, Pate JL. Effects of prostaglandin F2alpha and progesterone on the ability of bovine luteal cells to stimulate T lymphocyte proliferation. Biol Reprod 2003;69(2):695–700.
   PubMed Web of Science ®Google Scholar
• Xue L, Fergusson J, Salimi M, Panse I, Ussher JE, Hegazy AN, et al. Prostaglandin D2 and leukotriene E4 synergize to stimulate diverse TH2 functions and TH2 cell/neutrophil crosstalk. J Allergy Clin Immunol 2015;135(5):1358–66e1–11.
   Google Scholar
• Kin NW, Sanders VM. It takes nerve to tell T and B cells what to do. J Leukoc Biol 2006;79(6):1093–1104.
   PubMed Web of Science ®Google Scholar
• Guereschi MG, Araujo LP, Maricato JT, Takenaka MC, Nascimento VM, Vivanco BC, et al. Beta2-adrenergic receptor signaling in CD4+ Foxp3+ regulatory T cells enhances their suppressive function in a PKA-dependent manner. Eur J Immunol 2013;43(4):1001–1012.
   PubMed Web of Science ®Google Scholar
• Grus FH, Joachim SC, Bruns K, Lackner KJ, Pfeiffer N, Wax MB. Serum autoantibodies to alpha-fodrin are present in glaucoma patients from Germany and the United States. Invest Ophthalmol Vis Sci 2006;47(3):968–976.
   PubMed Web of Science ®Google Scholar
• Lim HW, Hillsamer P, Banham AH, Kim CH. Cutting edge: direct suppression of B cells by CD4+ CD25+ regulatory T cells. J Immunol. 2005;175(7):4180–4183.
   PubMed Web of Science ®Google Scholar
• Iikuni N, Lourenco EV, Hahn BH, La Cava A. Cutting edge: Regulatory T cells directly suppress B cells in systemic lupus erythematosus. J Immunol. 2009;183(3):1518–1522.
   PubMed Web of Science ®Google Scholar